Cite

HARVARD Citation

    Bhurani, M. et al. (2021). Pralatrexate in relapsed/refractory T-cell lymphoma: a retrospective multicenter study. Leukemia & lymphoma. 62 (2), pp. 330-336. [Online]. 
  
Back to record